These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20633178)

  • 21. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
    Halb L; Amann BJ; Bornemann-Cimenti H
    Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of botulinum toxin in pregnancy and its impact on female reproductive health.
    Li W; Tang M
    Expert Opin Drug Saf; 2020 Jan; 19(1):83-91. PubMed ID: 31868020
    [No Abstract]   [Full Text] [Related]  

  • 24. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence on botulinum toxin in selected disorders.
    Zakin E; Simpson D
    Toxicon; 2018 Jun; 147():134-140. PubMed ID: 29408357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Blitzer A; Brashear A; Comella C; Dubinsky R; Hallett M; Jankovic J; Karp B; Ludlow CL; Miyasaki JM; Naumann M; So Y;
    Neurology; 2008 May; 70(19):1699-706. PubMed ID: 18458230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M; Wissel J
    Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
    Del Sorbo F; Albanese A
    Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.
    Ferrari A; Maoret AR; Muzzini S; Alboresi S; Lombardi F; Sgandurra G; Paolicelli PB; Sicola E; Cioni G
    Res Dev Disabil; 2014 Oct; 35(10):2505-13. PubMed ID: 24995688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.
    Dunne JW; Gracies JM; Hayes M; Zeman B; Singer BJ;
    Clin Rehabil; 2012 Sep; 26(9):787-97. PubMed ID: 22308557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of different botulinum neurotoxin preparations.
    Abrams SB; Hallett M
    Toxicon; 2013 Jun; 67():81-6. PubMed ID: 23375537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin injections and hypertonic upper limbs. Which functional results?].
    Ferrapie AL; Vieillart A; Saint-Cast Y; Menei P; Richard I
    Ann Readapt Med Phys; 2005 May; 48(4):172-9. PubMed ID: 15848259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.